Gardenoside sustained and controlled release material and preparation method thereof

The geniposide sustained-release material prepared by ordered mesoporous carbon carrier and surface molecular imprinting technology solves the problems of low drug loading and poor physical stability, and realizes long-term, stable release and targeted delivery of geniposide, reducing adverse reactions.

CN121668335APending Publication Date: 2026-03-17GUANGDONG PHARMA UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202512000454.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-12-29
Publication Date
2026-03-17

AI Technical Summary

Technical Problem

Existing geniposide sustained-release formulations have low drug loading, poor physical stability, and high mass transfer resistance, making it difficult to achieve long-term and stable drug release, resulting in poor gastrointestinal irritation and pharmacokinetic properties.

Method used

Ordered mesoporous carbon was used as a carrier to construct a geniposide sustained-release material through surface molecular imprinting technology. Dimethylaminoethyl methacrylate was used as a functional monomer to carry out a surface polymerization reaction in an alkaline environment to form a surface molecular imprinted polymer. N,N'-bis(acryloyl)cysteine ​​was combined as a crosslinking agent to achieve highly selective adsorption and long-term sustained release of geniposide.

Benefits of technology

The prepared geniposide sustained-release material has a large specific surface area and good physical stability, which enables long-term and stable drug release, reduces gastrointestinal irritation, increases drug concentration at the target site, and reduces adverse reactions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121668335A_ABST
    Figure CN121668335A_ABST
Patent Text Reader

Abstract

The invention discloses a geniposide sustained and controlled release material and a preparation method thereof, which are characterized in that ordered mesoporous carbon is used as a carrier, geniposide is used as a template molecule, dimethylaminoethyl methacrylate is used as a functional monomer, and a surface polymerization reaction is carried out in an alkaline environment; and after the reaction is finished, eluting the template molecule, and drying to obtain the geniposide surface molecularly imprinted polymer. And adsorbing a geniposide solution by the polymer to obtain the geniposide sustained and controlled release material. The prepared geniposide sustained and controlled release material is large in specific surface area, good in physical stability and uniform in particle size, has excellent specific recognition capacity and long-acting sustained release performance, and can stably and accurately release geniposide medicine in a long-acting mode.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of controlled drug release, and more particularly to a geniposide sustained-release material and its preparation method. Background Technology

[0002] Geniposide (GEN) is the main active ingredient of Gardenia jasminoides, which has significant anti-inflammatory, neuroprotective, and hepatoprotective pharmacological activities, especially with therapeutic potential for stroke and neurodegenerative diseases. However, its clinical application is limited by two major issues: strong gastrointestinal irritation (nausea, diarrhea) and poor pharmacokinetic properties (poor oral absorption and short half-life). To overcome this application bottleneck, designing a sustained-release targeted drug delivery system is a key strategy: (1) Sustained-release formulation: loading the drug into biodegradable polymer microspheres to achieve stable release over several weeks, avoiding fluctuations in blood drug concentration and significantly reducing repeated gastrointestinal irritation caused by frequent administration; (2) Targeted delivery: directly avoiding or reducing local irritation through colonic targeting (bypassing the upper digestive tract) or nano-encapsulation (isolating mucosal contact); combined with brain-targeting modification (such as ligand-modified nanoparticles), increasing the drug concentration in brain lesions, and taking effect at a lower systemic dose, thereby systematically reducing adverse reactions. Currently available sustained-release formulations of geniposide are prepared as microspheres / nanoparticles through modification with hyaluronic acid, polyethylene glycol, chitosan, polylactic acid, etc. However, these formulations suffer from drawbacks such as low drug loading, the need for strict particle size control during preparation, poor physical stability, and risks of aggregation, sedimentation, or particle size increase. Therefore, there is an urgent need to develop a sustained-release material for geniposide with a large specific surface area, good physical stability, and uniform particle size, which is of great significance for improving the clinical efficacy of geniposide and reducing adverse reactions.

[0003] In recent years, nanoparticle drug delivery systems have become a research hotspot due to their excellent targeted delivery and controlled release capabilities. Among them, molecular imprinting technology (MIT), as a biomimetic technology that mimics the antigen-antibody specific recognition mechanism, has shown great application potential. Molecularly imprinted polymers (MIPs) constructed using this technology possess predetermined spatial structures and functional groups, exhibiting high affinity and selectivity for template molecules. However, traditional bulk imprinted polymers often suffer from problems such as excessively deep embedding of binding sites and high mass transfer resistance; surface molecular imprinting technology effectively solves these mass transfer bottlenecks by grafting imprinted layers onto the surface of a solid matrix. Compared to other nanocarriers, ordered mesoporous carbon (OMC), with its large specific surface area, uniform and tunable pore size distribution, and good biocompatibility, has become an ideal matrix for constructing efficient drug delivery systems. Summary of the Invention

[0004] To address the shortcomings of existing technologies, this invention provides a geniposide sustained-release material and its preparation method, which has a large specific surface area, good physical stability, uniform particle size, excellent specific recognition ability and long-lasting sustained-release performance, and can release geniposide drugs stably, for a long time, and accurately.

[0005] The objective of this invention is achieved through the following technical solution: A method for preparing a geniposide sustained-release material includes the following steps: using ordered mesoporous carbon as a carrier, geniposide as a template molecule, and dimethylaminoethyl methacrylate as a functional monomer, with a molar ratio of geniposide to dimethylaminoethyl methacrylate of 1:(2-6), a surface polymerization reaction is carried out in an alkaline environment (pH 8-10); after the reaction, the template molecule is eluted and dried to obtain geniposide surface molecularly imprinted polymers (SMIPs); then, the polymer is adsorbed onto a geniposide solution to obtain the geniposide sustained-release material.

[0006] The ordered mesoporous carbon was prepared by using copolymer F127 (poloxam F127) as a template agent and resorcinol-formaldehyde (the ratio of resorcinol to formaldehyde was 0.22 g: 0.2 mL) as a composite carbon source precursor. The mixture was dissolved in a hydrochloric acid aqueous solution system and subjected to a self-assembly reaction at 50-70 °C for 12-24 h. After drying, the product was carbonized at high temperature under a nitrogen (N2) protective atmosphere to obtain ordered mesoporous carbon.

[0007] The mass ratio of the template agent F127 to the carbon source component resorcinol is (1-4):1.

[0008] The specific operation of the surface polymerization reaction is as follows: ordered mesoporous carbon, template molecule geniposide and functional monomer dimethylaminoethyl methacrylate are mixed in Tris (tris(hydroxymethyl)aminomethane)-HCl buffer, ultrasonically dispersed for 10-30 min, and magnetically stirred at a constant temperature of 20-45℃ for 2-6 h to complete the pre-assembly; then a crosslinking agent and initiator are added, and after crosslinking initiation, a surface imprint layer is formed on the surface of the ordered mesoporous carbon.

[0009] The crosslinking agent and initiator is N,N'-bis(acryloyl)cystamine, which has good biocompatibility; its molar ratio with the functional monomer dimethylaminoethyl methacrylate is 3:1-1:3.

[0010] The reaction conditions for constructing the surface imprinted layer are: at room temperature, continuous oscillation or stirring to initiate the polymerization reaction for 6-24 hours.

[0011] The template molecule geniposide is first washed with methanol, then eluted in a constant temperature shaker with a mixed solution of methanol and glacial acetic acid (volume ratio of 4:1-9:1) for 36-96 hours, and then washed with methanol and water until neutral to remove the template molecule geniposide.

[0012] The geniposide sustained-release material described above was prepared using the method described above.

[0013] The reaction mechanism of the present invention is: (1) The preparation mechanism of ordered mesoporous carbon is mainly based on the template method. It forms a regular pore structure through self-assembly and has an ultra-high specific surface area. It is used as a carrier for surface molecular imprinted polymers. The crosslinking agent interacts with the template molecules and functional monomers through non-covalent or covalent interactions. Subsequently, a recognition site complementary to the template molecules is formed on the surface of the carrier. Finally, a cavity is formed by eluting the template. Under controlled conditions, highly selective adsorption and release of target molecules can be achieved. (2) In this invention, N,N'-bis(acryloyl)cysteine ​​is used as a crosslinking agent in surface molecularly imprinted polymers. Its mechanism involves achieving redox response characteristics through disulfide bond structure, thereby forming a stable network structure during polymerization. The crosslinking agent and functional monomers are connected through free radical polymerization mechanism in the polymerization reaction to form a three-dimensional crosslinked network, which provides structural stability for molecularly imprinted polymers. In surface molecularly imprinted polymers, the disulfide bond structure of the crosslinking agent can be broken in a reducing environment, leading to polymer degradation, thereby achieving controlled release of template molecules. This responsive characteristic makes imprinted polymers advantageous in targeted drug delivery or biosensing applications. In addition, the bisacryloyl structure of N,N'-bis(acryloyl)cysteine ​​can effectively increase the crosslinking density and improve the mechanical strength and selectivity of the polymer.

[0014] Compared with the prior art, the present invention has the following significant advantages: (1) Structural advantages: The present invention selects ordered mesoporous carbon as the core carrier. Its unique mesoporous channels not only provide abundant attachment sites for the growth of imprinted polymers and have a large specific surface area, but also effectively prevent the polymer layer from falling off, providing a structural basis for high drug loading.

[0015] (2) Performance advantages: The present invention utilizes geniposide as a template to construct a surface molecular imprinted layer, which endows the material with "molecular memory" function; the specific recognition site and the pore confinement effect of mesoporous carbon work together to achieve stable adsorption and long-term slow release of drugs, which can effectively inhibit the activity of inflammatory cells and reduce drug toxicity.

[0016] (3) Process advantages: The entire preparation process of this invention is carried out in an aqueous buffer solution under mild conditions; the selected Tris-HCl solvent, mesoporous carbon support and N,N'-bis(acryloyl)cysteine ​​crosslinking agent all have excellent biocompatibility and environmental friendliness, and meet the safety standards of green chemistry and pharmaceutical excipients. Attached Figure Description

[0017] Figure 1 This is a schematic diagram of the synthesis route and imprinting mechanism of the surface molecular imprinted polymer in this invention.

[0018] Figure 2 This is a scanning electron microscope (SEM) image of the microstructure of the ordered mesoporous carbon support prepared in this invention.

[0019] Figure 3 Figure 1 shows the particle size distribution test results (BJH) of the ordered mesoporous carbon support prepared in this invention. Figure 4 Isothermal adsorption kinetics curve of the target molecule geniposide on the surface molecularly imprinted polymer prepared in this invention.

[0020] Figure 5 The graph shows the cumulative in vitro release rate of the drug-loaded sustained-release material prepared in this invention under different pH conditions. Detailed Implementation

[0021] To make the technical solution, implementation idea, and beneficial effects of the present invention clearer and more explicit, the present invention will be further described in detail below with reference to specific embodiments. It should be understood that the specific embodiments described herein are only for explaining the present invention and are not intended to limit the scope of protection of the present invention. Any non-substantial modifications or equivalent substitutions based on the concept of the present invention should be covered within the patent protection scope of the present invention.

[0022] Example 1 Preparation of ordered mesoporous carbon: Template agent F127 and carbon precursor (resorcinol-formaldehyde) were prepared at a mass ratio of 2:1. The mixture was added to a double-layered reaction vessel, with 40 mL of hydrochloric acid solution added for every 100 mg of F127. The reaction was carried out at a constant temperature of 50 °C for 12 h. The resulting product was further processed and carbonized under a N2 atmosphere to obtain ordered mesoporous carbon with a regular pore structure, the morphology of which is shown in the figure. Figure 2 As shown, the particles have a rhombic dodecahedral structure and relatively uniform particle size, with an average diameter of approximately 0.5-0.8 μm, and possess a large specific surface area (686 m²). 2 / g), with an average pore size of 3.92nm ( Figure 3 (As shown).

[0023] Preparation of sustained-release materials: Using the ordered mesoporous carbon as a matrix, the template molecule geniposide and the functional monomer dimethylaminoethyl methacrylate were weighed at a molar ratio of 1:3 and placed in an Erlenmeyer flask. The above-mentioned mesoporous carbon and solvent (solid-liquid ratio of 1g mesoporous carbon: 25 mL solvent) were added. After ultrasonic dispersion for 30 min, the system was sealed and kept at 25 °C for 2 h for pre-assembly. Subsequently, the crosslinking agent N,N'-bis(acryloyl)cysteine ​​(with a molar ratio of 1:3 to dimethylaminoethyl methacrylate) was added, and the system was ultrasonically dispersed and polymerized at a constant temperature for 6 h under sealed conditions. After the reaction was completed, the polymer was collected by centrifugation, washed with methanol, and then deeply eluted with a methanol-glacial acetic acid mixture (volume ratio 4:1) in a constant temperature shaker for 48 h. After washing until neutral, the geniposide surface molecularly imprinted polymers (SMIPs) were obtained. Finally, 100 mg of the above SMIPs were weighed and placed in a geniposide solution with a concentration of 30 μg / mL. After adsorption for 1 h, the geniposide sustained-release material was obtained after separation and drying.

[0024] Figure 1 The preparation process was demonstrated, covering the entire process of carrier construction, polymerization coating, template elution, and drug re-adsorption. Figure 4 The adsorption kinetics of this material were demonstrated. Within a low concentration range of 2.5 mg / L – 40 mg / L, the adsorption capacity of SMIPs for GEN gradually increased with increasing initial GEN solution concentration. This is mainly attributed to the presence of sufficient adsorption sites on the SMIPs surface to adsorb GEN. With further increases in initial GEN concentration (40 mg / L – 60 mg / L), the rate of increase in adsorption capacity gradually slowed, indicating that the adsorption sites on the adsorbent surface began to approach saturation. Adsorption equilibrium was reached when the initial GEN concentration exceeded 40 mg / L, with a saturation adsorption capacity of 29.47 mg / g.

[0025] Example 2 Preparation of ordered mesoporous carbon: The mass ratio of F127 to carbon precursor was adjusted to 3:1. 45 mL of hydrochloric acid solution was added for every 100 mg of F127, dissolved in the reaction vessel, and the reaction temperature was increased to 60 °C, with the reaction time extended to 18 h. Subsequent carbonization steps were the same as above, yielding the ordered mesoporous carbon support.

[0026] Preparation of sustained-release materials: Using mesoporous carbon as a carrier, the molar ratio of template molecules to dimethylaminoethyl methacrylate was 1:4. The solvent volume was 20 mL per gram of mesoporous carbon. After 30 min of sonication and 2 h of pre-assembly at 35 °C, N,N'-bis(acryloyl)cysteine ​​(with a molar ratio of 1:2 to dimethylaminoethyl methacrylate) was added to initiate the polymerization reaction for 12 h. In the polymer elution step, a methanol-glacial acetic acid solution (4:1 v / v) was used for elution with shaking for 72 h, and the mixture was treated to neutral to obtain SMIPs. Drug loading stage: 100 mg of SMIPs was weighed and placed in a 40 μg / mL geniposide solution for adsorption for 1 h, and then dried to obtain the product.

[0027] Example 3 Preparation of ordered mesoporous carbon: The mass ratio of F127 to carbon precursor was set at 4:1. 50 mL of hydrochloric acid solution was used for every 100 mg of F127, and the reaction was carried out at 60 °C for 24 h. The support was obtained by carbonization treatment.

[0028] Preparation of sustained-release materials: Based on this carrier, the molar ratio of template molecule to functional monomer dimethylaminoethyl methacrylate was 1:5, and the solvent ratio was 1 g mesoporous carbon: 20 mL. Pre-assembly conditions were 25 ℃ with shaking for 2 h. Subsequently, N,N'-bis(acryloyl)cysteine ​​(with a molar ratio of 1:4 to dimethylaminoethyl methacrylate) was added for polymerization for 6 h. The elution process was extended to 96 h (methanol-glacial acetic acid volume ratio 6:1), and after washing and drying, SMIPs were obtained. Drug loading stage: 100 mg of SMIPs were saturated with 50 μg / mL geniposide solution for 1 h to prepare the final material.

[0029] Test Example 1: Evaluation of In Vitro Release Kinetics Accurately weigh 30 mg of the geniposide sustained-release material (GEN-loaded MIPs) prepared in this invention and disperse it in 50 mL of phosphate-buffered saline (PBS) at different pH values ​​(pH 4-10). Take samples at predetermined time points to determine the geniposide concentration and calculate the cumulative release rate. Figure 5As shown, the release rate of the material reached 81.71% in a simulated physiological environment (pH 4); while the release rate decreased in neutral (pH 7) or alkaline (pH 10) environments. This pH response characteristic indicates that the material can regulate drug release behavior according to the pH differences of the microenvironment of different organs in the body, providing experimental basis for achieving intelligent sustained and controlled release. This is significantly improved compared to the nanocellulose / polyvinyl alcohol self-healing geniposide hydrogel reported in Reference 1 (release rate less than 50%) and the chitosan-modified geniposide nanoparticles reported in Reference 2 (release rate about 60%). (Reference 1: Tang Lu, Preparation and mechanical property study of nanocellulose / polyvinyl alcohol self-healing hydrogel [D]. 2025, Harbin, Heilongjiang. Reference 2: Zhang Haiyan et al., Preparation and targeting of chitosan-modified geniposide polylactic acid-glycolic acid nanoparticles into the brain via nasal administration [J], Chinese Journal of New Drugs and Clinical Use, 2010, 29(6) 448-453.) Test Example 2: Adsorption Thermodynamics and Kinetic Evaluation Weigh 10 mg of the prepared surface molecularly imprinted polymer (SMTPs) and place them in 50 mL of geniposide PBS solutions (pH 4-7) at a series of concentrations (5-50 μg / mL). After adsorption equilibration for 30 min, determine the drug concentration in the supernatant and calculate the adsorption capacity. Figure 4 As shown, the adsorption capacity of the polymer increases with increasing drug concentration; when the concentration reaches 40 μg / mL, adsorption tends to saturate (equilibrium adsorption capacity is approximately 100 mg / g). Further increases in concentration thereafter do not significantly change the adsorption capacity. These results reveal that the adsorption behavior of the ordered mesoporous carbon-based imprinted material conforms to the Langmuir adsorption model, providing data support for determining the optimal drug loading process parameters.

[0030] The above description is merely an embodiment of the present invention, but the implementation of the present invention is not limited to the above embodiments. Any changes, modifications, substitutions, combinations, or simplifications made without departing from the spirit and principle of the present invention are equivalent substitutions and are included within the protection scope of the present invention.

Claims

1. A preparation method of a geniposide sustained and controlled release material, characterized by comprising the following steps: The surface molecular imprinting polymer of geniposide is prepared by using ordered mesoporous carbon as a carrier, geniposide as a template molecule, dimethylaminoethyl methacrylate as a functional monomer, and N, N'-bis (acryloyl) cystamine as a crosslinking agent and initiator in an alkaline environment; after the reaction is completed, the template molecule is eluted, and the surface molecular imprinting polymer of geniposide is obtained after drying; and then the polymer is used to adsorb a geniposide solution to obtain a geniposide controlled-release material. ​ 2. The preparation method of the controlled release material of geniposide according to claim 1, characterized in that: The molar ratio of geniposide to dimethylaminoethyl methacrylate is 1: (2-6); and the alkaline environment has a pH of 8-10.

3. The preparation method of the controlled release material of geniposide according to claim 1, characterized in that: The ordered mesoporous carbon is prepared by using copolymer F127 as a template agent and resorcinol-formaldehyde as a composite carbon source precursor; the template agent and the carbon source component are dissolved in a hydrochloric acid aqueous solution system, and a self-assembly reaction is performed at 50-70 DEG C for 12-24 h; and the product is dried and then carbonized under a nitrogen atmosphere at a high temperature to obtain the ordered mesoporous carbon.

4. The preparation method of the controlled release material of geniposide according to claim 3, characterized in that: The mass ratio of the template agent F127 to the carbon source component resorcinol is (1-4):

1.

5. The preparation method of the controlled release material of geniposide according to claim 1, characterized in that: The surface polymerization reaction is specifically performed as follows: the ordered mesoporous carbon, the template molecule geniposide and the functional monomer dimethylaminoethyl methacrylate are mixed in a Tris-HCl buffer solution, ultrasonically dispersed for 10-30 min, and then magnetically stirred at a constant temperature of 20-45 DEG C for 2-6 h to complete pre-assembly; and then the crosslinking agent and initiator are added, and a surface imprinting layer is formed on the surface of the ordered mesoporous carbon after crosslinking and initiation.

6. The preparation method of the controlled release material of geniposide according to claim 5, characterized in that: The crosslinking agent and initiator are N, N'-bis (acryloyl) cystamine; and the molar ratio of N, N'-bis (acryloyl) cystamine to the functional monomer dimethylaminoethyl methacrylate is 3: 1-1:

3.

7. The preparation method of the controlled release material of geniposide according to claim 5, characterized in that: The construction reaction conditions of the surface imprinting layer are as follows: the polymerization reaction is initiated by continuous oscillation or stirring for 6-24 h at room temperature.

8. The preparation method of the controlled release material of geniposide according to claim 1, characterized in that: The template molecule geniposide is eluted by first washing with methanol, then eluting in a mixed solution of methanol and glacial acetic acid in a constant-temperature oscillator for 36-96 h, and then washing with methanol and water respectively until neutral to remove the template molecule geniposide.

9. A geniposide modified release material, characterized by: The geniposide controlled-release material is prepared by using the method of any one of claims 1-8.